- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, January 21, 2022
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An editorial by the guest editor of the January 2022 Health Information Technology (IT) special issue of The American Journal of Managed Care® (AJMC®) was covered by Becker’s Hospital Review. The piece, “The Health Information Technology Special Issue: Continuing the Progress Toward Digital Transformation,” highlighted the research in the issue and the significant work that remains for provider organizations to integrate digital advancement as a key strategy in addressing some of the most pressing challenges that are transforming the health care landscape.
A piece by EHRIntelligence referenced a study published in the January 2022 Health IT special issue of AJMC®, titled “Approaches for Overcoming Barriers to Cross-Sector Data Sharing.” In the study, authors identified challenges to cross-sector data sharing and the approaches used to overcome these challenges in the Mid-Ohio Farmacy, a partnership to address food insecurity.
An article by Physician’s Weekly cited a study published in a supplement to AJMC®. The study, “The Emerging Role of the Type 2 Inflammatory Cascade in Atopic Diseases,” reviewed the clinical and economic burden of type 2 inflammatory diseases, including asthma, atopic dermatitis, and chronic rhinosinusitis with nasal polyps.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
